OptiNose Net Income 2016-2020 | OPTN

OptiNose net income from 2016 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
OptiNose Annual Net Income
(Millions of US $)
2019 $-110
2018 $-107
2017 $-62
2016 $2
2015 $-40
OptiNose Quarterly Net Income
(Millions of US $)
2020-09-30 $-21
2020-06-30 $-26
2020-03-31 $-29
2019-12-31 $-25
2019-09-30 $-29
2019-06-30 $-27
2019-03-31 $-29
2018-12-31 $-26
2018-09-30 $-25
2018-06-30 $-25
2018-03-31 $-31
2017-12-31 $-20
2017-09-30 $-17
2017-06-30 $-13
2017-03-31 $-12
2016-12-31
2016-09-30 $-9
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.214B $0.035B
OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and AVP-825 which are in clinical stage. OptiNose Inc. is headquartered in Pennsylvania, USA.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.626B 42.31
Takeda Pharmaceutical (TAK) Japan $57.159B 10.66
Astellas Pharma (ALPMY) Japan $30.180B 18.85
Eisai (ESALY) Japan $21.878B 19.06
Catalent (CTLT) United States $19.240B 57.55
Grifols, S.A (GRFS) Spain $13.098B 15.00
Neurocrine Biosciences (NBIX) United States $10.923B 85.96
Jazz Pharmaceuticals (JAZZ) Ireland $9.396B 15.18
Ionis Pharmaceuticals (IONS) United States $8.634B 84.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.530B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $8.433B 0.00
United Therapeutics (UTHR) United States $7.453B 15.87
IPSEN SA ADR (IPSEY) France $7.292B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.943B 402.83
Sage Therapeutics (SAGE) United States $4.609B 0.00
ChemoCentryx (CCXI) United States $4.457B 0.00
FibroGen (FGEN) United States $4.328B 0.00
PTC Therapeutics (PTCT) United States $4.323B 0.00
Hypermarcas (HYPMY) Brazil $4.041B 14.84
Cronos Group (CRON) Canada $3.789B 0.00
Corcept Therapeutics (CORT) United States $3.260B 31.53
Nektar Therapeutics (NKTR) United States $2.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.951B 15.06
Pacira BioSciences (PCRX) United States $2.948B 64.02
Revolution Medicines (RVMD) United States $2.866B 0.00
Xencor (XNCR) United States $2.787B 0.00
Tilray (TLRY) Canada $2.406B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.881B 0.00
USANA Health Sciences (USNA) United States $1.823B 16.05
Translate Bio (TBIO) United States $1.712B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.655B 14.16
BioCryst Pharmaceuticals (BCRX) United States $1.626B 0.00
Heron Therapeutics (HRTX) United States $1.609B 0.00
Endo (ENDP) Ireland $1.596B 2.42
Ocular Therapeutix (OCUL) United States $1.520B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.490B 10.35
ImmunoGen (IMGN) United States $1.437B 0.00
Trillium Therapeutics (TRIL) Canada $1.328B 0.00
Indivior (INVVY) United States $1.313B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.160B 0.00
ORGANOGENESIS (ORGO) United States $1.139B 0.00
Karyopharm Therapeutics (KPTI) United States $1.111B 0.00
Zogenix (ZGNX) United States $1.074B 0.00
Radius Health (RDUS) United States $1.010B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.957B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.828B 48.84
Calliditas Therapeutics AB (CALT) Sweden $0.789B 0.00
Aerie Pharmaceuticals (AERI) United States $0.787B 0.00
Aclaris Therapeutics (ACRS) United States $0.782B 0.00
VAXART, INC (VXRT) United States $0.782B 0.00
Esperion Therapeutics (ESPR) United States $0.723B 0.00
Acutus Medical (AFIB) United States $0.723B 0.00
Ardelyx (ARDX) United States $0.652B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.634B 0.00
Chinook Therapeutics (KDNY) United States $0.634B 0.00
Molecular Templates (MTEM) United States $0.602B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.582B 0.00
Flexion Therapeutics (FLXN) United States $0.569B 0.00
Harpoon Therapeutics (HARP) United States $0.551B 0.00
Siga Technologies (SIGA) United States $0.543B 15.26
PROFOUND MEDICL (PROF) Canada $0.509B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.501B 0.00
Jounce Therapeutics (JNCE) United States $0.500B 0.00
Akebia Therapeutics (AKBA) United States $0.486B 0.00
Altimmune (ALT) United States $0.475B 0.00
Summit Therapeutics (SMMT) United States $0.462B 0.00
DURECT (DRRX) United States $0.457B 0.00
Sundial Growers (SNDL) Canada $0.456B 0.00
TherapeuticsMD (TXMD) United States $0.450B 0.00
CASI Pharmaceuticals (CASI) United States $0.420B 0.00
Rafael Holdings (RFL) United States $0.412B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.393B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.373B 9.73
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.336B 0.00
Concert Pharmaceuticals (CNCE) United States $0.331B 0.00
Nature's Sunshine Products (NATR) United States $0.317B 20.44
Menlo Therapeutics (VYNE) United States $0.316B 0.00
Alpine Immune Sciences (ALPN) United States $0.312B 0.00
KalVista Pharmaceuticals (KALV) United States $0.289B 0.00
Redhill Biopharma (RDHL) Israel $0.286B 0.00
Lannett Co Inc (LCI) United States $0.281B 7.40
Infinity Pharmaceuticals (INFI) United States $0.263B 0.00
Xeris Pharmaceuticals (XERS) United States $0.262B 0.00
Jaguar Animal Health (JAGX) United States $0.261B 0.00
CTI BioPharma (CTIC) United States $0.254B 0.00
IMV INC (IMV) Canada $0.247B 0.00
Otonomy (OTIC) United States $0.238B 0.00
Calithera Biosciences (CALA) United States $0.219B 0.00
Oncternal Therapeutics (ONCT) United States $0.215B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.203B 0.00
Novan (NOVN) United States $0.191B 0.00
Aquestive Therapeutics (AQST) United States $0.191B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.177B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.168B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.161B 0.00
Heat Biologics (HTBX) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.151B 0.00
ProPhase Labs (PRPH) United States $0.148B 0.00
Onconova Therapeutics (ONTX) United States $0.147B 0.00
Lipocine (LPCN) United States $0.146B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.123B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.122B 0.00
ElectroCore (ECOR) United States $0.121B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.098B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
SCYNEXIS (SCYX) United States $0.089B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Recro Pharma (REPH) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.084B 161.83
Biomerica (BMRA) United States $0.082B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.079B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.077B 0.00
CV Sciences (CVSI) United States $0.070B 0.00
Vical (BBI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.066B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.056B 0.00
Regulus Therapeutics (RGLS) United States $0.051B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 25.38
Neos Therapeutics (NEOS) United States $0.042B 0.00
PolarityTE (PTE) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 5.91
Opiant Pharmaceuticals (OPNT) United States $0.040B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Midatech Pharma (MTP) United Kingdom $0.031B 0.00
Flex Pharma (SLRX) United States $0.030B 0.00
KemPharm (KMPH) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Cyanotech (CYAN) United States $0.021B 34.90
Bellicum Pharmaceuticals (BLCM) United States $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00